Rationalizing use of fluoroquinolones and pyrazinamide in the battle against multidrug-resistant tuberculosis
- PMID: 23815718
- DOI: 10.1164/rccm.201304-0697ED
Rationalizing use of fluoroquinolones and pyrazinamide in the battle against multidrug-resistant tuberculosis
Comment on
-
Contribution of moxifloxacin or levofloxacin in second-line regimens with or without continuation of pyrazinamide in murine tuberculosis.Am J Respir Crit Care Med. 2013 Jul 1;188(1):97-102. doi: 10.1164/rccm.201212-2328OC. Am J Respir Crit Care Med. 2013. PMID: 23593945 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
